Revolutionizing Healthcare and Drug Discovery: The Impact of Artificial Intelligence on Pharmaceutical Development

Abstract

Artificial intelligence (AI) is reshaping drug discovery and delivery in the pharmaceutical industry, fundamentally transforming traditional methods. In drug discovery, AI algorithms rapidly analyze vast biological and chemical datasets to identify potential drug candidates with unprecedented accuracy. Machine learning models predict compound efficacy and safety, accelerating earlystage drug development. AI also facilitates drug repurposing, uncovering new therapeutic uses for existing medications. At the drug delivery front, AI optimizes formulations and systems, enabling targeted and personalized approaches. Intelligent algorithms enhance the understanding of pharmacokinetics and pharmacodynamics, guiding the development of precision medicine strategies. This integration of AI not only expedites innovative drug discovery but also refines delivery mechanisms, promising more effective and tailored treatments with the potential to revolutionize patient care. The data-processing capabilities of AI drive digitalization and widespread utilization. Applications in drug discovery, development, repurposing, and clinical trials aim to alleviate human workload, expedite objectives, and foster innovation. Despite promising prospects, concerns about job displacement and stringent regulations accompany AI implementation. Emphasizing the intent to augment human labor rather than replace it entirely, the industry anticipates that AI will become a pivotal resource, propelling efficiency, innovation, and advancements in healthcare. This review emphasizes the role of AI in transforming drug discovery and delivery